- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01426477
Veritas in Non-Bridging Ventral Hernia Repair (VIBE)
January 18, 2018 updated by: Baxter Healthcare Corporation
The main study objective is to determine the frequency of hernia recurrence following use of Veritas Collagen Matrix.
Study Overview
Status
Terminated
Conditions
Study Type
Observational
Enrollment (Actual)
20
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Florida
-
Jacksonville, Florida, United States, 32224
- Mayo Clinic Department of Surgery
-
Lakeland, Florida, United States, 33805
- Watson Clinic Center for Research
-
-
Georgia
-
Atlanta, Georgia, United States, 30274
- Atlanta Colon & Rectal Surgery, P.A.
-
-
Virginia
-
Fredericksburg, Virginia, United States, 22407
- Pratt Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Study surgeons will recruit patients from within their own practice, or through their typical referring sources.
Description
Inclusion Criteria:
- Must be 18 years of age or older
- Ability to understand and read English
- Must be scheduled for open abdominal surgery for repair of primary ventral hernia or first recurrence of a ventral hernia with the Veritas Collagen Matrix using the underlay technique, with our without component separation
- Must be of ambulatory status
- Primary closure can be obtained during surgery
- Repair is such that one piece of Veritas can be used to reinforce the repair
Exclusion Criteria:
- Hernia is undetectable on physical exam
- There is evidence of existing cancer
- BMI ≥ 40
- Use of chronic immunosuppressive therapy, including steroids or cytotoxic agents
- Any condition that product labeling indicates would adversely affect participant safety, including sensitivity to bovine products
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Veritas Collagen Matrix
Observational study of subjects who undergo open ventral hernia repair using Veritas Collagen Matrix in an underlay technique.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Hernia recurrence
Time Frame: 2 Years
|
Recurrence will be evaluated through physical exam and/or CT scans at all study visits (30 days, 6 months, 1 year, and 2 years), or when patients present with symptoms, with primary endpoint at 2 years.
|
2 Years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of Medical and Surgical Complications
Time Frame: 2 years
|
Medical and Surgical Complications, including seroma, wound infection or other concurrent infection, hematoma, fistula, ileus, skin necrosis, wound dehiscence, or any other device-related events, will be evaluated through physical exam and/or CT scans at 30 days, 6 months, 1 year, and 2 years, or when patients present with symptoms.
These will be reported as total number of each complication within the total number of patients.
|
2 years
|
|
Change in Quality of Life
Time Frame: Baseline to 2 Years
|
Patients will complete questionnaires regarding physical functioning including activities of daily living, work productivity, and patient comfort at various timepoints after implant at baseline, and at all follow-up visits.
Outcomes will be reported in the change from baseline to 2-years.
|
Baseline to 2 Years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2011
Primary Completion (Actual)
August 1, 2017
Study Completion (Actual)
August 1, 2017
Study Registration Dates
First Submitted
August 29, 2011
First Submitted That Met QC Criteria
August 30, 2011
First Posted (Estimate)
August 31, 2011
Study Record Updates
Last Update Posted (Actual)
January 23, 2018
Last Update Submitted That Met QC Criteria
January 18, 2018
Last Verified
January 1, 2018
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 09-004
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hernia
-
University of California, DavisNot yet recruitingInguinal Hernia | Hernia | Hiatal Hernia | Ventral Hernia | Diastasis Recti | Hernia Abdominal WallUnited States
-
University of NebraskaLifeCellCompletedHiatal Hernia | Esophageal Hernia | Hernia, Esophageal | Hernia, Paraesophageal | Paraesophageal Hiatal Hernia | Sliding Esophageal Hernia | Sliding Hiatal HerniaUnited States
-
Muhammet Mustafa VuralRecruitingInguinal Hernia | Femoral Hernia | Obturator HerniaTurkey
-
Advanced Medical Solutions Ltd.CompletedInguinal Hernia | Hernia | Femoral Hernia | Groin HerniaUnited States
-
GSVM Medical CollegeCompleted
-
Assiut UniversityNot yet recruitingAbdominal Hernia
-
Universitaire Ziekenhuizen KU LeuvenRecruiting
-
Zealand University HospitalCompletedInguinal Hernia | Femoral HerniaDenmark
-
Washington University School of MedicineMusculoskeletal Transplant FoundationCompleted
-
Anne Arundel Health System Research InstituteMedtronic - MITGCompletedGrade I Ventral Hernia | Grade II Ventral HerniaUnited States